MedTrace Logo

Preoperative Ondansetron Lozenge for Prevention of Post-Spinal Shivering in Caesarean Section

NCT06423807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-08

No results posted yet for this study

Summary

The aim of this study is to estimate the role of ondansetron lozenge on prevention of post-spinal shivering in cesarean section.

Conditions

  • Ondansetron Lozenge
  • Post-Spinal Shivering
  • Cesarean Section

Interventions

DRUG

Ondansetron lozenge

Patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Mohammed S Elsharkawy, MD · Faculty of Medicine Tanta University, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-21
Primary Completion
2024-09-29
Completion
2024-09-29

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06423807 on ClinicalTrials.gov